Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -203 | -150 | -45 | -246 | -162 |
| Depreciation Amortization | 5 | 3 | 2 | 9 | 5 |
| Accounts receivable | N/A | N/A | N/A | 1 | 1 |
| Accounts payable and accrued liabilities | 7 | 5 | 12 | 37 | 16 |
| Other Working Capital | 137 | 93 | 28 | 183 | 116 |
| Other Operating Activity | -7 | -5 | -12 | -89 | -68 |
| Operating Cash Flow | $-61 | $-54 | $-16 | $-106 | $-92 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | -2 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 100 | 100 |
| Debt Repayment | -4 | -3 | -2 | -6 | -4 |
| Other Financing Activity | 52 | 39 | 3 | 31 | 54 |
| Financing Cash Flow | $48 | $36 | $1 | $126 | $150 |
| Beginning Cash Position | 19 | 19 | 19 | 0 | 0 |
| End Cash Position | 5 | 0 | 4 | 19 | 57 |
| Net Cash Flow | $-14 | $-18 | $-15 | $18 | $57 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61 | -54 | -16 | -106 | -92 |
| Capital Expenditure | N/A | N/A | N/A | -2 | -2 |
| Free Cash Flow | -61 | -54 | -16 | -108 | -94 |